IntrinsicIntrinsic
← Scroll for more →

Recent Updates — MO

October 29, 2026View Source ↗

Altria Group reported third-quarter adjusted diluted earnings per share of $1.52, a 4.8% increase from the prior year period, driven by higher pricing in its smokeable products segment. The company raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.66 to $5.74, representing growth of 4.5% to 6.0%. Additionally, Altria's Board authorized a $1 billion expansion of its existing share repurchase program, which now expires on December 31, 2027. The company operates in the tobacco and nicotine products industry.

October 9, 2026View Source ↗

Altria Group entered into an extension agreement on October 7, 2026, amending its $3.0 billion senior unsecured five-year revolving credit agreement with JPMorgan Chase Bank and Citibank as administrative agents. The amendment extends the expiration date of the facility from October 24, 2029, to October 24, 2030, while all other terms remain in full force. Altria operates in the tobacco industry.

August 28, 2026View Source ↗

Altria Group, Inc. increased its Board of Directors from ten to eleven members and elected Steven W. Presley as a director effective August 27, 2026. The board appointed Mr. Presley to the Compensation and Talent Development, Innovation, and Finance committees, affirming his status as an independent director under New York Stock Exchange standards. Altria operates in the tobacco industry, manufacturing combustible cigarettes, smokeless tobacco, oral nicotine pouches, and e-vapor products.

July 30, 2026View Source ↗

Altria Group reported second-quarter net revenues of $6.1 billion, essentially unchanged year-over-year, with adjusted diluted EPS rising 2.8% to $1.48. The company narrowed its full-year 2026 adjusted diluted EPS guidance to a range of $5.61 to $5.72, representing growth of 3.5% to 5.5%. Altria returned nearly $3.9 billion to shareholders through dividends and share repurchases in the first half, including $55 million in buybacks during Q2. The firm also raised its capital expenditure outlook for 2026 to between $375 million and $450 million to support manufacturing consolidation. Altria operates in the tobacco industry, producing combustible cigarettes, oral tobacco products, and smoke-free alternatives.